(DARE) – Business Wire
-
Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Va
-
Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer
Back to DARE Stock Lookup